Πλοήγηση ανά Συγγραφέα "Vlachoyiannopoulos, P. G."
-
Antithyroid antibodies in antiphospholipid syndrome: prevalence and clinical associations
Mavragani, C. P.; Danielides, S.; Zintzaras, E.; Vlachoyiannopoulos, P. G.; Moutsopoulos, H. M. (2009)Autoimmune thyroid disease has been associated with several systemic autoimmune disorders. However, limited data are available regarding the prevalence and clinical associations of thyroid autoimmunity in antiphospholipid ... -
Cyclophosphamide therapy for renal involvement in SLE: When to discontinue in responders? When to consider it has failed?
Vlachoyiannopoulos, P. G.; Samarkos, M.; Fotia, M.; Zintzaras, E.; Boletis, J.; Moutsopoulos, H. M. (2005) -
Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma
Danielides, S.; Mavragani, C. P.; Katsakoulas, I.; Zintzaras, E.; Drosos, A. A.; Vlachoyiannopoulos, P. G.; Moutsopoulos, H. M. (2011)Objectives: Thyroid dysfunction in the setting of systemic sclerosis (SSc) has been described previously. We aimed to determine the prevalence of anti-thyroid antibodies (ATA) in a large SSc cohort and to ascertain whether ... -
Morbidity, Mortality, and Organ Damage in Patients with Antiphospholipid Syndrome
Grika, E. P.; Ziakas, P. D.; Zintzaras, E.; Moutsopoulos, H. M.; Vlachoyiannopoulos, P. G. (2012)Objective. To describe morbidity, organ damage, mortality, and cause of death in patients with antiphospholipid syndrome (APS). Methods. Descriptive analysis of 135 patients. Patients were clustered according to initial ... -
Upregulation of antiphospholipid (APL) antibody responses by cyclophosphamide
Vlachoyiannopoulos, P. G.; Zintzaras, E.; Katsifis, G. E.; Toya, S.; Tzioufas, A.; Moutsopoulos, H. M. (2007) -
Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus
Vlachoyiannopoulos, P. G.; Toya, S. P.; Katsifis, G.; Zintzaras, E.; Tzioufas, A. G.; Moutsopoulos, H. M. (2008)Objective. We have observed several cases of patients with systemic lupus erythematosus (SLE) who developed antiphospholipid antibodies (aPL) or full blown antiphospholipid syndrome (APS) after being successfully treated ...